Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2026 07:17 ET | Source: PCI Biotech Holding ASA

Notice of Extraordinary General Meeting, proposed company dissolution and delisting

Oslo, Norway 23 February 2026 – An extraordinary general meeting of PCI Biotech Holding ASA (‘PCI Biotech’ or ‘Company’) will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on...
January 29, 2026 11:50 ET | Source: PCI Biotech Holding ASA

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

Oslo (Norway), 29 January 2026 – PCI Biotech (OSE: PCIB) refers to its latest announcement of 8 January 2026 regarding the discontinuation of all R&D operations and the continued exploration of...
January 08, 2026 08:10 ET | Source: PCI Biotech Holding ASA

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options

Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has...
October 23, 2025 04:35 ET | Source: PCI Biotech Holding ASA

PCI Biotech update

Oslo (Norway), 23 October 2025 – PCI Biotech (OSE: PCIB) today provides an update on the ongoing evaluation of its operations. Reference is made to the company’s announcements dated 18th August 2025...
September 25, 2025 09:36 ET | Source: PCI Biotech Holding ASA

PCI Biotech update on future operations

Oslo (Norway), 25 September 2025 – PCI Biotech (OSE:PCIB) today announces an update on the ongoing evaluation of its future operations. Reference is made to the announcement on 18th August 2025...
August 29, 2025 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech half-year interim 2025 report

Oslo (Norway), 29 August 2025 – PCI Biotech (OSE: PCIB), today announces its half-yearly 2025 interim report. Please find enclosed the interim report and presentation. Highlights review ...
August 26, 2025 10:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to first half 2025 results presentation and corporate update

Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2025 interim report on Friday, 29 August 2025, 08:30am – 09:00am CET (local time). ...
August 22, 2025 08:15 ET | Source: PCI Biotech Holding ASA

Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding...
August 22, 2025 05:09 ET | Source: PCI Biotech Holding ASA

Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36%...
August 18, 2025 14:40 ET | Source: PCI Biotech Holding ASA

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations

Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector...